Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Relapse of Clostridium difficile infection with previous trial of vancomycin or fidaxomicin~Exclusion Criteria:~1. Pregnancy or breastfeeding~2. Does not speak or understand the Danish language~3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin~4. fulminant colitis which contraindicates medical treatment~5. physician's evaluation that the patient cannot tolerate project inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- FMT (Type: EXPERIMENTAL): Fecal microbiota transplantation (FMT) following 4-10 days of vancomycin 125 mg x 4, using cryopreserved feces from a healthy anonymous donor
- Fidaxomicin (Type: ACTIVE_COMPARATOR): 10 days fidaxomicin 200 mg x 2 daily
- Vancomycin (Type: ACTIVE_COMPARATOR): 10 days vancomycin 125 x 4 daily

Based on this trial design, predict the completion outcome and termination type (if applicable).